Genetic variant of glutathione peroxidase 1 in autism

Brain and Development

Volumn 32, Issue 2, 2010, Pages 105-109

  Ming, Xue ^a   Johnson, William G ^b   Stenroos, Edward S ^b   Mars, Audrey ^c   Lambert, George H ^d   Buyske, Steven ^e  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c Hunterdon Medical Center   (United States)

^d ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^e RUTGERS UNIVERSITY   (United States)

Author keywords

Autistic disorder; Glutathione peroxidase 1; Oxidative stress; Polymorphism; Transmission disequilibrium test

Indexed keywords

ALANINE; GLUTATHIONE PEROXIDASE 1; MANGANESE SUPEROXIDE DISMUTASE;

ARTICLE; AUTISM; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; TRINUCLEOTIDE REPEAT;

ALLELES; AUTISTIC DISORDER; GENOTYPE; GLUTATHIONE PEROXIDASE; HUMANS; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; TRINUCLEOTIDE REPEATS;

EID: 73749086125     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2008.12.017     Document Type: Article

References (44)

1. Golse B., Debray-Ritzen P., Durosay P., Puget K., and Michelson A.M. Alterations in two enzymes: superoxide dismutase and glutathione peroxidase in developmental infantile psychosis (infantile autism). Rev Neurol (Paris) 134 (1978) 699-705
2. Sogut S., Zoroglu S.S., Ozyurt H., Yilmaz H.R., Ozugurlu F., and Sivasli E. Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clin Chim Acta 331 (2003) 111-117
3. Yorbik O., Sayal A., Akay C., Akbiyik D.I., and Sohmen T. Investigation of antioxidant enzymes in children with autistic disorder. Prostaglandins Leukot Essent Fatty Acids 67 (2002) 341-343
4. Zoroglu S.S., Armutcu F., Ozen S., Gurel A., Sivasli E., Yetkin O., et al. Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. Eur Arch Psychiatry Clin Neurosci 254 (2004) 143-147
5. James S.J., Cutler P., Melnyk S., Jernigan S., Janak L., Gaylor D.W., et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80 (2004) 1611-1617
6. Minshew N.J., Goldstein G., Dombrowski S.M., Panchalingam K., and Pettegrew J.W. A preliminary 31P MRS study of autism: evidence for undersynthesis and increased degradation of brain membranes. Biol Psychiatry 33 (1993) 762-773
7. Chugani D.C., Sundram B.S., Behen M., Lee M.L., and Moore G.J. Evidence of altered energy metabolism in autistic children. Prog Neuropsychopharmacol Biol Psychiatry 23 (1999) 635-641
8. Coleman M., and Blass J.P. Autism and lactic acidosis. J Autism Dev Disord 15 (1985) 1-8
9. Moreno H., Borjas L., Arrieta A., Saez L., Prassad A., Estevez J., et al. Clinical heterogeneity of the autistic syndrome: a study of 60 families. Invest Clin 33 (1992) 13-31
10. Dolske M.C., Spollen J., McKay S., Lancashire E., and Tolbert L. A preliminary trial of ascorbic acid as supplemental therapy for autism. Prog Neuropsychopharmacol Biol Psychiatry 17 (1993) 765-774
11. Chez M.G., Buchanan C.P., Aimonovitch M.C., Becker M., Schaefer K., Black C., et al. Double-blind, placebo-controlled study of l-carnosine supplementation in children with autistic spectrum disorders. J Child Neurol 17 (2002) 833-837
12. Ming X., Stein T.P., Brimacombe M., Johnson W.G., Lambert G.H., and Wagner G.C. Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins Leukot Essent Fatty Acids 73 (2005) 379-384
13. Montuschi P., Barnes P.J., and Roberts II L.J. Isoprostanes: markers and mediators of oxidative stress. FASEB J 18 (2004) 1791-1800
14. Zoroglu S.S., Yurekli M., Meram I., Sogut S., Tutkun H., Yetkin O., et al. Pathophysiological role of nitric oxide and adrenomedullin in autism. Cell Biochem Funct 21 (2003) 55-60
15. Edelson S.B., and Cantor D.S. The neurotoxic etiology of the autistic spectrum disorder: a replicative study. Toxicol Ind Health 16 (2000) 239-247
16. Edelson S.B., and Cantor D.S. Autism: xenobiotic influences. Toxicol Ind Health 14 (1998) 799-811
17. Buyske S., Williams T.A., Mars A.E., Stenroos E.S., Ming S.X., Wang R., et al. Analysis of case-parent trios at a locus with a deletion allele: association of GSTM1 with autism. BMC Genet 7 (2006) 8
18. Williams T.A., Mars A.E., Buyske S.G., Stenroos E.S., Wang R., Factura-Santiago M.F., et al. Risk of autistic disorder in affected offspring of mothers with a glutathione S-transferase P1 haplotype. Arch Pediatr Adolesc Med 161 (2007) 356-361
19. Lei X.G., Cheng W.H., and McClung J.P. Metabolic regulation and function of glutathione peroxidase-1. Annu Rev Nutr 27 (2007) 41-61
20. Graf W.D., Pippenger C.E., and Shurtleff D.B. Erythrocyte antioxidant enzyme activities in children with myelomeningocele. Dev Med Child Neurol 37 (1995) 900-905
21. Pippenger C.E., Meng X., and Rothner A.D. Free radical scavenging enzyme activity profiles in risk assessment of idiosyncratic drug reactions. Probable mechanism for valproate-induced acute pancreatitis and hepatotoxicity. In: Levy R.H., and Penry J.K. (Eds). Idiosyncratic reactions to valproate: clinical risk patterns and mechanisms of toxicity (1991), Raven Press, New York 75-88
22. Williams P.G., and Hersh J.H. A male with fetal valproate syndrome and autism. Dev Med Child Neurol 39 (1997) 632-634
23. Christianson A.L., Chesler N., and Kromberg J.G.R. Fetal valproate syndrome: clinical and neurodevelopmental features in two sibling pairs. Dev Med Child Neurol 36 (1994) 357-369
24. Moore S.J., Turnpenny P., Quinn A., Glowver S., Lloyd D.J., Montgomery T., et al. A clinical study of 57 children with fetal anticonvulsant syndrome. J Med Genet 37 (2000) 489-497
25. Knight J.A., Onay U.V., Wells S., Li H., Shi E.J., Andrulis I.L., et al. Genetic variants of GPX1 and SOD2 and breast cancer risk at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 13 (2004) 146-149
26. Winter J.P., Gong Y.Y., Grant P.J., and Wild C.P. Glutathione peroxidase 1 genotype is associated with an increased risk of coronary artery disease. Coron Artery Dis 14 (2003) 149-153
27. De Haan J.B., Bladier C.C., Griffiths P., Kelner M., O'Shea R.D., Cheung N.S., et al. Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide. J Biol Chem 273 (1998) 22528-22536
28. Fu Y., Cheng W.H., Porres J.M., Ross D.A., and Lei X.G. Knockout of cellular glutathione peroxidase gene renders mice susceptible to diquat-induced oxidative stress. Free Radic Biol Med 27 (1999) 605-611
29. Moscow J.A., Schmidt L., Ingram D.T., Gnarra J., Jonson B., and Cowan K.H. Loss of heterozygosity of the human cytosolic glutathione peroxidase 1 gene in lung cancer. Carcinogenesis 15 (1994) 2769-2773
30. Lord C., Rutter M., and Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24 (1994) 659-685
31. Lord C., Risi S., Lambrecht L., Cook Jr. E.H., Leventhal B.L., DiLavore P.C., et al. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 30 (2000) 205-223
32. Lange K., Cantor R., Horvath S., Perola M., Sabatti C., Sinsheimer J., et al. Version 4.0: a complete package for the exact genetic analysis of discrete traits in pedigree and population data sets. Am J Hum Genet 69 (2001) A1886
33. Flohe L. The selenoprotein glutathione peroxidase. In: Dolphin D, Avramovic O, Poulson R, editors. Glutathione: chemical, biochemical and medical aspects. New York: John Wiley; 1989. p. 644-731.
34. Shen Q., Townes P.L., Padden C., and Newburger P.E. An in-frame trinucleotide repeat in the coding region of the human cellular glutathione peroxidase (GPX1) gene: in vivo polymorphism and in vitro instability. Genomics 23 (1994) 292-294
35. Hardie L.J., Briggs J.A., Davidson L.A., Allan J.A., King R.F.G.J., Williams G.I., et al. Glutathione peroxidase 1 genotype is associated with an increased risk of coronary artery disease. Carcinogenesis 21 (2000) 167-172
36. Jefferies S., Kote-Jarai Z., Goldgar D., Houlston R., Frazer-Williams M.J., A'Hern R., et al. Association between polymorphisms of the GPX1 gene and second primary tumours after index squamous cell cancer of the head and neck. Oral Oncol 41 (2005) 455-461
37. Kote-Jarai Z., Durocher F., Edwards S.M., Hamoudi R., Jackson R.A., Ardern-Jones A., et al. Association between the GCG polymorphism of the selenium dependent GPX1 gene and the risk of young onset prostate cancer. Prostate Cancer Prostatic Dis 5 (2002) 189-192
38. Ratnasinghe D., Tangrea J.A., Andersen M.R., Barrett M.J., Virtamo J., Taylor P.R., et al. Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res 60 (2000) 6381-6383
39. Ichimura Y., Habuchi T., Tsuchiva N., Wang L., Oyama C., Sato K., et al. Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant. J Urol 172 (2004) 728-732
40. Solodilova M.A., Ivanov V.P., Polonikov A.V., Khoroshaia I.V., Kozhukhov M.A., and Panfilov V.I. Heterozygosity of 198LEU mutant allele in glutathione peroxidase-1 gene as a risk factor of bronchial asthma associated with smoking. Ter Arkh 79 (2007) 33-36
41. Forsberg L., de Faire U., and Morgenstern R. Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys 389 (2001) 84-93
42. Ravn-Haren G., Olsen A., Tjonneland A., Dragsted L.O., Nexo B.A., Wallin H., et al. Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis 27 (2006) 820-825
43. Hamanishi T., Furuta H., Kato H., Doi A., Tamai M., Shimomura H., et al. Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in Japanese type 2 diabetic patients. Diabetes 53 (2004) 2455-2460
44. Cox D.G., Tamimi R.M., and Hunter D.J. Gene x Gene interaction between MnSOD and GPX-1 and breast cancer risk: a nested case-control study. BMC Cancer 31 (2006) 217